相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy
Giuseppe Schepisi et al.
CANCERS (2021)
PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells Differences Across Histologic and TCGA-based Molecular Subgroups
Annukka Pasanen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-Ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
Hao Chen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Pathogenesis and Clinical Management of Uterine Serous Carcinoma
Li Zhang et al.
CANCERS (2020)
Endometrial Cancer
Karen H. Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A multiomics comparison between endometrial cancer and serous ovarian cancer
Hui Zhong et al.
PEERJ (2020)
Expression of Immunomodulatory Molecules PD-1, PD-L1, and PD-L2, and their Relationship With Clinicopathologic Characteristics in Endometrial Cancer
Nuran Sungu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
U. A. Matulonis et al.
ANNALS OF ONCOLOGY (2019)
Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer
Umran Kucukgoz Gulec et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Andrew A. Davis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma
Aline Talhouk et al.
CLINICAL CANCER RESEARCH (2019)
Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein Deficiency
Zaibo Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer
Jisup Kim et al.
GYNECOLOGIC ONCOLOGY (2018)
An Update on Immunotherapy for Solid Tumors: A Review
Toan Pham et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases
Yao Wang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue
Alper Karalok et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors
Emily A. Sloan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Immunotherapy for gynecologic cancers
John B. Liao
GYNECOLOGIC ONCOLOGY (2016)
Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Patients With Endometrial Cancer
Jisun Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma
Ulas Solmaz et al.
TUMORI (2016)
Optimal cytoreduction, depth of myometrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomas
Ulas Solmaz et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma
Ulas Solmaz et al.
TUMORI (2016)
A clinically applicable molecular-based classification for endometrial cancers
A. Talhouk et al.
BRITISH JOURNAL OF CANCER (2015)
Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study
Haider Mandi et al.
GYNECOLOGIC ONCOLOGY (2015)
The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and dear cell carcinoma according to the SEER registry
Malcolm D. Mattes et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)
Targeted therapy in the treatment of uterine serous carcinoma
Carlton L. Schwab et al.
PHARMACOGENOMICS (2015)
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
Katherine A. Hoadley et al.
CELL (2014)
Population-based treatment and outcomes of Stage I uterine serous carcinoma
Louis J. M. van der Putten et al.
GYNECOLOGIC ONCOLOGY (2014)
Cancer beyond organ and tissue specificity: Next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers
D. Heim et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer
Gunjal Garg et al.
GYNECOLOGIC ONCOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Uterine papillary serous cancer: A review of the literature
Marcela G. del Carmen et al.
GYNECOLOGIC ONCOLOGY (2012)
Optimal surgical debulking in uterine papillary serous carcinoma affects survival
Kristia Patsavas et al.
GYNECOLOGIC ONCOLOGY (2011)
Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma
Alexander B. Olawaiye et al.
GYNECOLOGIC ONCOLOGY (2008)
Role of cytoreduction in stage III and IV uterine papillary serous carcinoma
M. Bijoy Thomas et al.
GYNECOLOGIC ONCOLOGY (2007)
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases
BM Slomovitz et al.
GYNECOLOGIC ONCOLOGY (2003)
The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma
RE Bristow et al.
GYNECOLOGIC ONCOLOGY (2001)
分享论文
